Back to Jones Financial Companies LLLP Jones Financial Companies LLLP

SLN

7 quarters

Position history for Jones Financial Companies LLLPJones Financial Companies LLLP's holdings in Silence Therapeutics Plc

Yes. Jones Financial Companies holds 2,500 shares of SLN (Silence Therapeutics), worth $27,950, as of its Q3 2026 13F filing. The share count is unchanged from Q2 2026. Jones Financial Companies has held SLN since Q1 2025, across 7 quarterly 13F filings.

Current Value

$27,950

Current Shares

2,500

Total Value Change

+$19,350

Total Shares Change

0

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q3
Latest
Unchanged
2,500
0.0%
$27,9500.0%$10.93
0
2026-Q2
Unchanged
2,500
0.0%
$25,3500.0%$10.98
0
2026-Q1
Unchanged
2,500
0.0%
$12,3250.0%$5.27
0
2025-Q4
Unchanged
2,500
0.0%
$15,2000.0%$6.08
0
2025-Q3
Unchanged
2,500
0.0%
$13,8500.0%$5.19
0
2025-Q2
Unchanged
2,500
0.0%
$14,4750.0%$5.80
0
2025-Q1
New
2,500
-
$8,6000.0%$2.82
25

Other major holders of SLN: FMR LLC, Millennium Management LLC, Janus Henderson Group Ltd., Polar Capital Holdings Plc

Optional analytics helps us improve. How it’s used